This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the ongoing HERIZON-GEA-01 trial in 1L GEA (zanidatamab + chemotherapy ± tislelizumab)
Ticker(s): JAZZ, ZYMEWho's the expert?
Institution: MD Anderson
- Professor, Department of GI Medical Oncology at MD Anderson.
- Main interest is in GI oncology research, particularly focusing on gastric and esophagael cancers.
- Chair of Gastric Cancer and Esophagael Cancer Guidelines of the National Comprehensive Cancer Network for more than 25 years.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
